| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/18/1987 | EP0214647A2 Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes |
| 03/18/1987 | EP0214588A2 Cyclic oxime |
| 03/18/1987 | EP0214501A2 Emulsion compositions for administration of sparingly water soluble ionizable basic hydrophobic drugs |
| 03/18/1987 | EP0214299A1 Preparation of 5-fluoro-2'-deoxyuridine esters for intraarterial administration |
| 03/18/1987 | CN86106150A Chewable capsules |
| 03/17/1987 | US4650785 Pharmaceutical composition having an excellent absorption property |
| 03/17/1987 | US4650678 Readily dissolvable lyophilized fibrinogen formulation |
| 03/17/1987 | US4650675 Oligonucleotide conjugates |
| 03/17/1987 | US4650664 Oral mopidamol preparation |
| 03/17/1987 | CA1219217A1 Antiinflammatory analgesic gelled ointments |
| 03/17/1987 | CA1219216A1 Ph independent controlled release tablets |
| 03/11/1987 | EP0214092A1 Enhanced absorption of psychoactive 2-aryl-pyrazolo quinolines as a solid molecular dispersion in polyvinylpyrrolidone |
| 03/11/1987 | EP0213918A2 A process for producing a medical resin composition. |
| 03/11/1987 | EP0213881A2 The use of amphipathic molecules for radioimaging and therapy with conjugates of monoclonal or polyclonal antibodies |
| 03/11/1987 | EP0213851A2 Injectable semi-solid formulations |
| 03/11/1987 | EP0213811A2 Bateriocin-Targeted compounds for cancer therapy |
| 03/11/1987 | EP0213761A2 Stable sodium aspirin tablet compositions |
| 03/11/1987 | EP0213717A2 Iodophor containing suppository |
| 03/11/1987 | EP0213632A2 Moisture-retaining preparation for dermal use |
| 03/11/1987 | EP0213581A2 Monoclonal antibodies against tumour-associated glycoproteins, process for their preparation and their use |
| 03/11/1987 | EP0213552A2 Oily suspension for intrarectal infusion |
| 03/11/1987 | EP0213523A2 Pharmaceutical compositions containing acylated phospholipids |
| 03/11/1987 | EP0213514A2 Aqueous liquid preparation |
| 03/05/1987 | EP0145779A4 Preparation and method for the treatment of acne. |
| 03/04/1987 | EP0212959A2 Sustained-release formulation containing an amin acid polymer with a lower alkyl (C1-C4) polar solvent |
| 03/04/1987 | EP0212853A2 Parenteral phenytoin compositions |
| 03/04/1987 | EP0212641A2 Taste masking compositions |
| 03/04/1987 | EP0212596A2 Luprostiol solution |
| 03/04/1987 | EP0211991A1 Substained release tablets and method for preparation thereof |
| 03/04/1987 | CN86105087A Injectable sustained release formulation |
| 03/03/1987 | US4647454 Stable interferon β composition and a method of stabilizing interferon β |
| 03/03/1987 | US4647280 Binder for low density lipoproteins |
| 03/03/1987 | US4646730 Polyvinylpyrrolidone, silver sulfadiazine |
| 03/03/1987 | CA1218606A1 Pharmaceutical composition and its nasal or vaginal use |
| 03/03/1987 | CA1218605A1 Pharmaceutical composition and its rectal use |
| 03/03/1987 | CA1218602A1 Interferon gel formulations |
| 03/03/1987 | CA1218598A1 Aqueous solution containing lipid-soluble pharmaceutical substance |
| 02/25/1987 | EP0211691A2 Injectable sustained release formulation |
| 02/25/1987 | EP0211601A2 Stabilization of growth promoting hormones |
| 02/25/1987 | EP0211592A2 Pharmaceutical dosage unit |
| 02/25/1987 | EP0211555A2 Transparent silicone compositions |
| 02/25/1987 | EP0211550A2 Composition for personal care products comprising alkoxylated fatty alcohol and polysiloxane |
| 02/25/1987 | EP0211434A2 Rectal dosage forms for ceftriaxone |
| 02/25/1987 | EP0211268A2 Slow-release topical formulations |
| 02/25/1987 | EP0211267A2 Continuous release peptide compositions |
| 02/25/1987 | EP0211042A1 Liposome composition and method |
| 02/25/1987 | CN86106228A Process for preparing anti-enteritis capsule |
| 02/25/1987 | CN86105639A Rectal dosage forms |
| 02/25/1987 | CN86101087A Benzoyl urea compounds process for production |
| 02/25/1987 | CN85105953A Active compound depot |
| 02/25/1987 | CN85105086A Modified process for synthesizing azone, a skin permeation promoter |
| 02/24/1987 | US4645830 Ph controlled |
| 02/24/1987 | US4645794 Quaternary nitrogen containing polyvinyl alcohol polymers for use in skin conditioning, cosmetic and pharmaceutical formulations |
| 02/24/1987 | US4645768 Treatment of cardiovascular disorders |
| 02/24/1987 | US4645670 Process for the stabilization of hematin |
| 02/24/1987 | CA1218308A1 Method for protecting and healing gastro-duodenal mucosa and the liver of mammals |
| 02/24/1987 | CA1218302A1 Hoof ointment |
| 02/17/1987 | US4644031 Coating for pharmaceutical dosage forms |
| 02/17/1987 | US4643988 Antiarthritic agents |
| 02/17/1987 | US4643895 Anti-cancer drugs for the treatment of leukaemias I, constituted by the chain A of ricin and a specific monoclanal antibody |
| 02/17/1987 | US4643856 Mixing with a miscible liquid solvent and gelling agent, cooling then evaporation |
| 02/17/1987 | US4643850 Silane modified ester mixtures, a method for their preparation, and their use in pharmaceutical and cosmetic preparations |
| 02/17/1987 | CA1218077A1 Resinate of a substituted carboxylic acid, the preparation and use thereof, and pharmaceutical compositions containing it |
| 02/11/1987 | CN85106763A Process for preparation of injection composition comprising an antifacterial aminoglycoside |
| 02/10/1987 | US4642316 Complexing with choline, ethylenediamine |
| 02/10/1987 | US4642111 Sustained release |
| 02/10/1987 | CA1217718A Plasminogen activator derivatives |
| 02/10/1987 | CA1217671A Stabilized solid compositions |
| 02/04/1987 | EP0210759A2 Suppositories containing analgesics, antipyretics or anti-inflammatory agents |
| 02/04/1987 | EP0210661A1 Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting |
| 02/04/1987 | EP0210412A2 Anchoring membrane ingredient conjugate, and its use |
| 02/04/1987 | CN86105526A Pharmaceutical dosage unit |
| 02/04/1987 | CN86104740A Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting |
| 02/04/1987 | CN85104164A Process for preparing covalent conjunct agent of bacterial polysaccharide and immunogen protein |
| 02/03/1987 | US4640835 Physiologically stable anticoagulants |
| 02/03/1987 | CA1217425A1 Oxytetracyclin-solutions |
| 02/03/1987 | CA1217424A1 Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors |
| 01/31/1987 | CN85101396A Biodegradable matrix and methods for producing same |
| 01/29/1987 | WO1987000530A1 Protein conjugates of bis-indole alkaloids, bis-indole alkaloids, their preparation and application |
| 01/28/1987 | EP0209975A1 Anti-inflammatory analgesic adhesive preparation |
| 01/28/1987 | EP0209726A2 Soluble collagen sponge |
| 01/28/1987 | CN86105483A Stabilization of growth promoting hormones |
| 01/28/1987 | CN86104283A Process for the preparation of an injectable ready-to use solution containing an antitumor anthracycline glycoside |
| 01/27/1987 | US4639370 Pharmaceutical composition |
| 01/24/1987 | CN85102334A Process for preparing dihydropyridine preparation |
| 01/24/1987 | CN85101697A Dihydropyridine combination preparations and process for their preparation |
| 01/24/1987 | CN85101689A Nifedipine preparation and its process |
| 01/21/1987 | EP0209509A2 Anti-oxidants for use in the protection of easily oxidizable compounds, and a method for the protection of easily oxidizable compounds and application of the anti-oxidants |
| 01/21/1987 | EP0209277A1 Heteropolysaccharide and its production and use |
| 01/21/1987 | EP0209121A2 Sustained-release pharmaceutical composition and process for its preparation |
| 01/21/1987 | EP0208971A2 Solid galenical forms for oral application containing 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9S)-erythromycin, and process for their preparation |
| 01/21/1987 | CN86104449A Heteropolysaccharide s-657 |
| 01/20/1987 | US4638049 Antitumor protein hybrid and process for the preparation thereof |
| 01/20/1987 | US4637930 Transdermal formulation of nicardipine hydrochloride |
| 01/20/1987 | US4637834 Aqueous protein solutions which are stable towards denaturing, processes for their preparation and their use |
| 01/20/1987 | CA1216791A1 Conjugates associating, by covalent bond, an enzyme with an antibody, and medicinal associations using the said conjugates |
| 01/17/1987 | CN85102133A A process for preparing an occlusion compound of 2-nitroxymethyl-6-chloropyridine with beta-cyclodextrin |
| 01/15/1987 | WO1987000201A1 Epithelial cells expressing foreign genetic material |
| 01/15/1987 | WO1987000196A1 Protection of proteins and the like |
| 01/15/1987 | WO1987000056A1 Solubilization of proteins for pharmaceutical compositions using polymer conjugation |